David Krempa, Chief Business Officer: Eton Pharmaceuticals ETON Planned sale · Filed 25/12/12

Trade details

Type: Planned sale notice
Stock: Eton Pharmaceuticals ETON
Person: David KrempaChief Business Officer
Planned sale date: 25/12/12
Filed: 25/12/12

$127.4K to be sold

Eton Pharmaceuticals trades, last 26 weeks

What else happened in Eton Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/11/12~01/11

David Krempa's recent trades

David KrempaChief Business Officer
Planned saleEton Pharmaceuticals
Planned sale
Eton Pharmaceuticals
ETON
$1.6M
25,000 sh
$1.6M
Filed 08/24
Traded 08/24
David KrempaChief Business Officer
SellEton Pharmaceuticals
Sell
Eton Pharmaceuticals
ETON
$1.2M
37,524 sh
$1.2M
Filed 05/27
Traded 05/26
David KrempaChief Business Officer
SellEton Pharmaceuticals
Sell
Eton Pharmaceuticals
ETON
$1.1M
32,963 sh
$1.1M
Filed 05/27
Traded 05/22
David KrempaChief Business Officer
SellEton Pharmaceuticals
Sell
Eton Pharmaceuticals
ETON
$619.3K
19,679 sh
$619.3K
Filed 05/27
Traded 05/27
David KrempaChief Business Officer
SellEton Pharmaceuticals
Sell
Eton Pharmaceuticals
ETON
$315.6K
9,315 sh
$315.6K
Filed 05/27
Traded 05/22

David Krempa, Chief Officer — plans to sell 7,545 sh of Eton Pharmaceuticals ETON · $127.4K · around 12/12 | Whalegun